• Mashup Score: 5

    In this latest episode of ASTCT Talks, Dr. Andrés Gómez De León sits down with Dr. Aaron Logan to discuss development of current techniques for quantifying measurable residual disease (MRD) in acute lymphoblastic leukemia and MRD’s relation to transplantation and cell therapy. They discuss the concept of MRD and its relevance in the treatment of leukemia as a prognostic marker and to help guide…

    Tweet Tweets with this article
    • ICYMI: In the latest ASTCT Talks episode, @GomezDLeonMD sat down with @hemedoc to discuss the development of current techniques for quantifying MRD in acute lymphoblastic leukemia & MRD’s relation to transplantation & cell therapy. Listen now: https://t.co/RPTm3sh9Ms #leusm

  • Mashup Score: 4

    Drs. Karl and Spencer discuss the worry surrounding lean mass loss while using GLP-1 agonists. Learn: – The usual amount of lean mass loss during weight loss – How much was lost in small subset using semaglutide and tirzepatide – What is the clinical relevance – and more!

    Tweet Tweets with this article
    • Is lean mass loss with GLP-1s a concern? If any physicians care about lean mass, it's the #DocsWhoLift @DrKarlNadolsky and I discuss the semaglutide and tirzepatide body composition data and the clinical relevance. https://t.co/E9QPXWlLbE

  • Mashup Score: 0

    Create, distribute, host, and monetize your podcast, 100% free.

    Tweet Tweets with this article
    • 🆕 Battles & Debates in Sports Orthopaedics | ISAKOS Podcast series ❇️ Recurrent anterior shoulder instability | Soft vs. Bony Procedures Listen to the episode: https://t.co/0RGcxX5Mw5 @ManosBR @marykmulcaheymd @berte2be https://t.co/EGaKiRRkdg

  • Mashup Score: 2

    Create, distribute, host, and monetize your podcast, 100% free.

    Tweet Tweets with this article
    • Stay away from those who recommend batteries of tests without understanding pretest probabilities and also clinics that recommend $1000s of supplements/medicines without addressing the underlying issue. @Jordan_theCoach @AustinBaraki @DrKarlNadolsky https://t.co/Tg10w6FDkI

  • Mashup Score: 1

    Create, distribute, host, and monetize your podcast, 100% free.

    Tweet Tweets with this article
    • In the latest ASTCT Talks episode, @GomezDLeonMD sits down with @hemedoc to discuss the development of current techniques for quantifying MRD in acute lymphoblastic leukemia & MRD's relation to transplantation & cell therapy. Listen now: https://t.co/RPTm3sh9Ms https://t.co/DOpzTd9LJB

  • Mashup Score: 1

    In this latest episode of ASTCT Talks, Dr. Andrés Gómez De León sits down with Dr. Aaron Logan to discuss development of current techniques for quantifying measurable residual disease (MRD) in acute lymphoblastic leukemia and MRD’s relation to transplantation and cell therapy. They discuss the concept of MRD and its relevance in the treatment of leukemia as a prognostic marker and to help guide…

    Tweet Tweets with this article
    • I really enjoyed talking about MRD in ALL with my friend @GomezDLeonMD on this episode of the @ASTCT Talks podcast! Great conversation. Hope some find it useful! #leusm #bmtsm #celltx https://t.co/IwAKX1UWUH